Moreover, these tumours often contain additional areas of astrocytic differentiation and display a typical immunohistochemical profile of IDH-mutant astrocytoma, with loss of nuclear ATRX expression, nuclear accumulation of p53, and positive staining for IDH R132H in the vast majority of tumours. This evidence concerns the gene IDH1 and astrocytoma (excluding glioblastoma).